XML 49 R24.htm IDEA: XBRL DOCUMENT v3.22.0.1
Other Balance Sheet Details (Tables)
12 Months Ended
Dec. 31, 2021
Other Balance Sheet Details [Abstract]  
Inventories
Inventory consisted of the following:
December 31,
(in millions)20212020
Raw materials$11.2 $16.6 
Work in process3.6 2.4 
Finished goods15.7 9.0 
Total inventory$30.5 $28.0 
Property and Equipment
Property and equipment, net, consisted of the following:
December 31,
(in millions)20212020
Tenant improvements$34.9 $29.5 
Scientific equipment51.6 39.2 
Computer equipment18.1 13.9 
Furniture and fixtures5.9 3.7 
110.5 86.3 
Less accumulated depreciation(51.9)(41.7)
Total property and equipment, net$58.6 $44.6 
Accounts Payable and Accrued Liabilities
Accounts payable and accrued liabilities consisted of the following:
December 31,
(in millions)20212020
Accrued employee related costs $50.6 $38.2 
Revenue-related reserves for discounts and allowances62.7 34.6 
Accrued development costs32.4 32.9 
Current branded prescription drug fee28.6 23.6 
Accounts payable and other accrued liabilities51.5 39.4 
Total accounts payable and accrued liabilities$225.8 $168.7 
Reconciliation of Cash, Cash Equivalents and Restricted Cash
The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same such amounts shown in the consolidated statements of cash flows.
December 31,
(in millions)20212020
Cash and cash equivalents$340.8 $187.1 
Restricted cash3.2 3.2 
Total cash, cash equivalents and restricted cash$344.0 $190.3